Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1172 ARTÍCULOS , VIENDO DEL 1 AL 15

Cellular and molecular actions of Methylene Blue in the nervous system

Oz M, Lorke DE, Hasan M, Petroianu GA.

Med Res Rev. 2011 Jan;31(1):93-117. doi: 10.1002/med.20177.

Alzheimer's disease as homeostatic responses to age-related myelin breakdown

Bartzokis G.

Neurobiol Aging. 2011 Aug;32(8):1341-71. doi: 10.1016/j.neurobiolaging.2009.08.007. Epub 2009 Sep 22.

Cortical thickness and voxel-based morphometry in posterior cortical atrophy and typical Alzheimer's disease

Lehmann M, Crutch SJ, Ridgway GR, Ridha BH, Barnes J, Warrington EK, Rossor MN, Fox NC.

Neurobiol Aging. 2011 Aug;32(8):1466-76. doi: 10.1016/j.neurobiolaging.2009.08.017. Epub 2009 Sep 25.

No replication of genetic association between candidate polymorphisms and Alzheimer's disease

Cousin E, Macé S, Rocher C, Dib C, Muzard G, Hannequin D, Pradier L, Deleuze JF, Génin E, Brice A, Campion D.

Neurobiol Aging. 2011 Aug;32(8):1443-51. doi: 10.1016/j.neurobiolaging.2009.09.004. Epub 2009 Nov 3.

Efficacy of PPAR-γ agonist pioglitazone in mild Alzheimer disease

Sato T, Hanyu H, Hirao K, Kanetaka H, Sakurai H, Iwamoto T.

Neurobiol Aging. 2011 Sep;32(9):1626-33. doi: 10.1016/j.neurobiolaging.2009.10.009. Epub 2009 Nov 17.

TGF-β1 pathway as a new target for neuroprotection in Alzheimer's disease

Caraci F, Battaglia G, Bruno V, Bosco P, Carbonaro V, Giuffrida ML, Drago F, Sortino MA, Nicoletti F, Copani A.

CNS Neurosci Ther. 2011 Aug;17(4):237-49. doi: 10.1111/j.1755-5949.2009.00115.x. Epub 2009 Nov 19.

Fractal analysis of amyloid plaques in Alzheimer's disease patients and mouse models

Pirici D, Van Cauwenberghe C, Van Broeckhoven C, Kumar-Singh S.

Neurobiol Aging. 2011 Sep;32(9):1579-87. doi: 10.1016/j.neurobiolaging.2009.10.010. Epub 2009 Dec 16.

When the zebra loses its stripes: Semantic priming in early Alzheimer's disease and semantic dementia

Laisney M, Giffard B, Belliard S, de la Sayette V, Desgranges B, Eustache F.

Cortex. 2011 Jan;47(1):35-46. doi: 10.1016/j.cortex.2009.11.001. Epub 2009 Nov 10.

Efficacy and safety of Cerebrolysin in moderate to moderately severe Alzheimer's disease: results of a randomized, double-blind, controlled trial investigating three dosages of Cerebrolysin

Alvarez XA, Cacabelos R, Sampedro C, Aleixandre M, Linares C, Granizo E, Doppler E, Moessler H.

Eur J Neurol. 2011 Jan;18(1):59-68. doi: 10.1111/j.1468-1331.2010.03092.x.

Specific anatomic associations between white matter integrity and cognitive reserve in normal and cognitively impaired elders

Arenaza-Urquijo EM, Bosch B, Sala-Llonch R, Solé-Padullés C, Junqué C, Fernández-Espejo D, Bargalló N, Rami L, Molinuevo JL, Bartrés-Faz D.

Am J Geriatr Psychiatry. 2011 Jan;19(1):33-42. doi: 10.1097/JGP.0b013e3181e448e1.

Long-term outcome and prediction models of activities of daily living in Alzheimer disease with cholinesterase inhibitor treatment

Wattmo C, Wallin ÅK, Londos E, Minthon L.

Alzheimer Dis Assoc Disord. 2011 Jan-Mar;25(1):63-72. doi: 10.1097/WAD.0b013e3181f5dd97.

Impaired adaptive cellular responses to oxidative stress and the pathogenesis of Alzheimer's disease

Texel SJ, Mattson MP.

Antioxid Redox Signal. 2011 Apr 15;14(8):1519-34. doi: 10.1089/ars.2010.3569. Epub 2011 Feb 17.

Non-cholinergic pharmacotherapy approaches to Alzheimer's disease: the use of non-steroidal anti-inflammatory drugs

Tsartsalis S, Panagopoulos PK, Mironidou-Tzouveleki M.

CNS Neurol Disord Drug Targets. 2011 Feb;10(1):133-9. doi: 10.2174/187152711794488629.

Development and validity of the Family Stigma in Alzheimer's disease Scale (FS-ADS)

Werner P, Goldstein D, Heinik J.

Alzheimer Dis Assoc Disord. 2011 Jan-Mar;25(1):42-8. doi: 10.1097/WAD.0b013e3181f32594.

Contemporary approaches to Alzheimer's disease and frontotemporal dementia

Roberson ED.

Methods Mol Biol. 2011;670:1-9. doi: 10.1007/978-1-60761-744-0_1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias